Advertisement

Role of Membrane Cholesterol in Leishmanial Infection

Conference paper
Part of the Advances in Experimental Medicine and Biology book series (volume 749)

Abstract

Leishmania is an obligate intracellular parasite that can invade and survive within host macrophages resulting in leishmaniasis, a major public health problem worldwide. The entry of intracellular parasites in general involves interaction with the plasma membrane of host cells. The molecular mechanisms involved in internalization of Leishmania are poorly characterized. Cholesterol in host cell membranes has recently been found to be necessary for binding and internalization of Leishmania. We propose that the reduction in leishmanial infection by cholesterol depletion/sequestration could be exploited to develop novel therapeutic strategies against leishmaniasis. This approach has the advantage of avoiding the commonly encountered drug resistance problem in tackling leishmaniasis.

Keywords

Visceral Leishmaniasis Membrane Cholesterol Cholesterol Depletion Host Macrophage Pathogen Entry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

FITC

Fluorescein isothiocyanate

GPCR

G-protein coupled receptor

MβCD

Methyl-β-cyclodextrin

Notes

Acknowledgments

Work in A.C.’s laboratory was supported by the Council of Scientific and Industrial Research, Govt. of India. A.C. is an Adjunct Professor at the Special Centre for Molecular Medicine of Jawaharlal Nehru University (New Delhi, India) and Indian Institute of Science Education and Research (Mohali, India), and Honorary Professor of the Jawaharlal Nehru Centre for Advanced Scientific Research (Bangalore, India). A.C. gratefully acknowledges J.C. Bose Fellowship (Dept. Science and Technology, Govt. of India). Some of the work described in this article was carried out by former members of A.C.’s group whose contributions are gratefully acknowledged. We gratefully acknowledge Sandeep Shrivastava for help in creating Figs. 14.1 and 14.2. We thank members of our laboratory for critically reading the manuscript.

References

  1. Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112:2993–3002PubMedGoogle Scholar
  2. Atger VM, de la Llera MM, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH (1997) Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99:773–780PubMedCrossRefGoogle Scholar
  3. Bansal D, Bhatti HS, Sehgal R (2005) Role of cholesterol in parasitic infections. Lipids Health Dis 4:10PubMedCrossRefGoogle Scholar
  4. Berman J (2003) Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16: 397–401PubMedCrossRefGoogle Scholar
  5. Bolard J (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864:257–304PubMedCrossRefGoogle Scholar
  6. Campbell SM, Crowe SM, Mak J (2001) Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 22:217–227PubMedCrossRefGoogle Scholar
  7. Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W (2009) HIV entry in macrophages is dependent on intact lipid rafts. Virology 386:192–202PubMedCrossRefGoogle Scholar
  8. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S (2005) Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175: 3214–3224PubMedGoogle Scholar
  9. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control ? Nat Rev Microbiol 5:873–882PubMedCrossRefGoogle Scholar
  10. Chaudhuri A, Chattopadhyay A (2011) Transbilayer organization of membrane cholesterol at low concentrations: implications in health and disease. Biochim Biophys Acta 1808:19–25PubMedCrossRefGoogle Scholar
  11. Clemente R, de Parseval A, Perez M, de la Torre JC (2009) Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J Virol 83:2655–2662PubMedCrossRefGoogle Scholar
  12. Cossart P, Roy CR (2010) Manipulation of host membrane machinery by bacterial pathogens. Curr Opin Cell Biol 22:547–554PubMedCrossRefGoogle Scholar
  13. Danthi P, Chow M (2004) Cholesterol removal by methyl-β-cyclodextrin inhibits poliovirus entry. J Virol 78:33–41PubMedCrossRefGoogle Scholar
  14. Davis ME, Brewster ME (2004) Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 3:1023–1035PubMedCrossRefGoogle Scholar
  15. de Kruijff B, Demel RA (1974) Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes III. Molecular structure of the polyene antibiotic cholesterol complexes. Biochim Biophys Acta 339:57–70PubMedCrossRefGoogle Scholar
  16. Gatfield J, Pieters J (2000) Essential role for cholesterol in entry of Mycobacteria into macrophages. Science 288:1647–1650PubMedCrossRefGoogle Scholar
  17. Gimpl G (2010) Cholesterol-protein interaction: methods and cholesterol reporter molecules. Subcell Biochem 51:1–45PubMedCrossRefGoogle Scholar
  18. Goluszko P, Nowicki B (2005) Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun 73:7791–7796PubMedCrossRefGoogle Scholar
  19. Handman E, Bullen DVR (2002) Interaction of Leishmania with the host macrophage. Trends Parasitol 18:332–334PubMedCrossRefGoogle Scholar
  20. Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, Lomasney JW, Haldar K (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301:1734–1736PubMedCrossRefGoogle Scholar
  21. Härtel S, Diehl HA, Ojeda FS (1998) Methyl-β-cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity-sensitive dyes. Anal Biochem 258:277–284PubMedCrossRefGoogle Scholar
  22. Hawkes DJ, Mak J (2006) Lipid membrane; a novel target for viral and bacterial pathogens. Curr Drug Targets 7:1615–1621PubMedCrossRefGoogle Scholar
  23. Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199PubMedCrossRefGoogle Scholar
  24. Holz RW (1974) The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes. Ann NY Acad Sci 235:469–479PubMedCrossRefGoogle Scholar
  25. Jacobson K, Mouritsen OG, Anderson RGW (2007) Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7–14PubMedCrossRefGoogle Scholar
  26. Khanna KV, Whaley KJ, Zeitlin L, Moench TR, Mehrazar K, Cone RA, Liao Z, Hildreth JE, Hoen TE, Shultz L, Markham RB (2002) Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 109:205–211PubMedGoogle Scholar
  27. Lauer S, VanWye J, Harrison T, McManus H, Samuel BU, Hiller NL, Mohandas N, Haldar K (2000) Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 19:3556–3564PubMedCrossRefGoogle Scholar
  28. Lee CJ, Lin HR, Liao CL, Lin YL (2008) Cholesterol effectively blocks entry of flavivirus. J Virol 82:6470–6480PubMedCrossRefGoogle Scholar
  29. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE (2001) Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retrovir 17:1009–1019PubMedCrossRefGoogle Scholar
  30. Lingwood D, Simons K (2010) Lipid rafts as a membrane-organizing principle. Science 327:46–50PubMedCrossRefGoogle Scholar
  31. Liscum L, Underwood KW (1995) Intracellular cholesterol transport and compartmentation. J Biol Chem 270:15443–15446PubMedCrossRefGoogle Scholar
  32. Marty A, Finkelstein A (1975) Pores formed in lipid bilayer membranes by nystatin: differences in its one-sided and two-sided action. J Gen Physiol 65:515–526PubMedCrossRefGoogle Scholar
  33. Mouritsen OG (2010) The liquid-ordered state comes of age. Biochim Biophys Acta 1798:1286–1288PubMedCrossRefGoogle Scholar
  34. Mouritsen OG, Zuckermann MJ (2004) What’s so special about cholesterol? Lipids 39: 1101–1113PubMedCrossRefGoogle Scholar
  35. Mukherjee S, Maxfield FR (2004) Membrane domains. Annu Rev Cell Dev Biol 20:839–866PubMedCrossRefGoogle Scholar
  36. Olivier M, Gregory DJ, Forget G (2005) Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18: 293–305PubMedCrossRefGoogle Scholar
  37. Paila YD, Chattopadhyay A (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51:439–466PubMedCrossRefGoogle Scholar
  38. Paila YD, Murty MRVS, Vairamani M, Chattopadhyay A (2008) Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta 1778:1508–1516PubMedCrossRefGoogle Scholar
  39. Paila YD, Saha B, Chattopadhyay A (2010) Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 399:429–433PubMedCrossRefGoogle Scholar
  40. Peyron P, Bordier C, N’Diaye EN, Maridonneau-Parini I (2000) Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J Immunol 165:5186–5191PubMedGoogle Scholar
  41. Pucadyil TJ, Chattopadhyay A (2006) Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 45:295–333PubMedCrossRefGoogle Scholar
  42. Pucadyil TJ, Chattopadhyay A (2007) Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol 23:49–53PubMedCrossRefGoogle Scholar
  43. Pucadyil TJ, Shrivastava S, Chattopadhyay A (2004a) The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor. Biochem Biophys Res Commun 320:557–562PubMedCrossRefGoogle Scholar
  44. Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A (2004b) Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol 133: 145–152PubMedCrossRefGoogle Scholar
  45. Pucadyil TJ, Shrivastava S, Chattopadhyay A (2005) Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin1A receptors. Biochem Biophys Res Commun 331:422–427PubMedCrossRefGoogle Scholar
  46. Ren X, Glende J, Yin J, Schwegmann-Wessels C, Herrler G (2008) Importance of cholesterol for infection of cells by transmissible gastroenteritis virus. Virus Res 137:220–224PubMedCrossRefGoogle Scholar
  47. Riethmüller J, Riehle A, Grassmé H, Gulbins E (2006) Membrane rafts in host-pathogen interactions. Biochim Biophys Acta 1758:2139–2147PubMedCrossRefGoogle Scholar
  48. Rittig MG, Bogdan C (2000) Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16:292–297PubMedCrossRefGoogle Scholar
  49. Rodríguez NE, Gaur U, Wilson ME (2006) Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol 8:1106–1120PubMedCrossRefGoogle Scholar
  50. Rosenberger CM, Brumell JH, Finlay BB (2000) Microbial pathogenesis: lipid rafts as pathogen portals. Curr Biol 10:R823–R825PubMedCrossRefGoogle Scholar
  51. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, Majumdar S, Mukhopadhyaya R, Saha B (2009) Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 10:273–280PubMedCrossRefGoogle Scholar
  52. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845–858PubMedCrossRefGoogle Scholar
  53. Samuel BU, Mohandas N, Harrison T, McManus H, Rosse W, Reid M, Haldar K (2001) The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem 276:29319–29329PubMedCrossRefGoogle Scholar
  54. Shin J-S, Abraham SN (2001) Caveolae as portals of entry for microbes. Microbes Infect 3: 755–761PubMedCrossRefGoogle Scholar
  55. Shin J-S, Gao Z, Abraham SN (2000) Involvement of cellular caveolae in bacterial entry into mast cells. Science 289:785–788PubMedCrossRefGoogle Scholar
  56. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A (2010) Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors. Biochemistry 49:5426–5435PubMedCrossRefGoogle Scholar
  57. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110:597–603PubMedGoogle Scholar
  58. Simons K, Ikonen E (2000) How cells handle cholesterol. Science 290:1721–1725PubMedCrossRefGoogle Scholar
  59. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39PubMedCrossRefGoogle Scholar
  60. Tewary P, Veena K, Pucadyil TJ, Chattopadhyay A, Madhubala R (2006) The sterol-binding antibiotic nystatin inhibits entry of non-opsonized Leishmania donovani into macrophages. Biochem Biophys Res Commun 339:661–666PubMedCrossRefGoogle Scholar
  61. Tsamaloukas A, Szadkowska H, Slotte JP, Heerklotz H (2005) Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. Biophys J 89:1109–1119PubMedCrossRefGoogle Scholar
  62. van der Goot FG, Harder T (2001) Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13:89–97PubMedCrossRefGoogle Scholar
  63. van der Meer-Janssen YPM, van Galen J, Batenburg JJ, Helms JB (2010) Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome. Prog Lipid Res 49:1–26PubMedCrossRefGoogle Scholar
  64. Vieira FS, Corrêa G, Einicker-Lamas M, Coutinho-Silva R (2010) Host-cell lipid rafts: a safe door for micro-organisms? Biol Cell 102:391–407PubMedCrossRefGoogle Scholar
  65. Villalaín J (1996) Location of cholesterol in model membranes by magic-angle-sample-spinning NMR. Eur J Biochem 241:586–593PubMedCrossRefGoogle Scholar
  66. Wolday D, Berhe N, Akuffo H, Britton S (1999) Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 15:182–187PubMedCrossRefGoogle Scholar
  67. World Health Organization Website http://www.who.int/leishmaniasis/en/
  68. Zidovetzki R, Levitan I (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311–1324PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Centre for Cellular and Molecular BiologyCouncil of Scientific and Industrial ResearchHyderabadIndia

Personalised recommendations